These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36899073)

  • 41. Digital health, digital medicine, and digital therapeutics in cardiology: current evidence and future perspective in Japan.
    Nomura A
    Hypertens Res; 2023 Sep; 46(9):2126-2134. PubMed ID: 37258624
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Navigating the future of health care with AI-driven digital therapeutics.
    Vasdev N; Gupta T; Pawar B; Bain A; Tekade RK
    Drug Discov Today; 2024 Sep; 29(9):104110. PubMed ID: 39034025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
    J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Insights into insurance coverage for digital therapeutics: A qualitative study of US payer perspectives.
    Lumbreras AG; Hurwitz JT; Liang X; Schippers S; Phillip K; Bhattacharjee S; Waters HC; Malone DC
    J Manag Care Spec Pharm; 2024 Apr; 30(4):313-325. PubMed ID: 38555623
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness analysis of digital therapeutics for home-based cardiac rehabilitation for patients with atrial fibrillation after catheter ablation.
    Liu T; Tang Z; Cai C; Wu N; Jia J; Yang G; Zhang W
    Digit Health; 2023; 9():20552076231211548. PubMed ID: 38025109
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Real-world usage of digital health applications (DiGA) in rheumatology: results from a German patient survey.
    Labinsky H; Gupta L; Raimondo MG; Schett G; Knitza J
    Rheumatol Int; 2023 Apr; 43(4):713-719. PubMed ID: 36543961
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ethics of digital therapeutics (DTx).
    Refolo P; Sacchini D; Raimondi C; Spagnolo AG
    Eur Rev Med Pharmacol Sci; 2022 Sep; 26(18):6418-6423. PubMed ID: 36196692
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-effectiveness of digital therapeutics for essential hypertension.
    Nomura A; Tanigawa T; Kario K; Igarashi A
    Hypertens Res; 2022 Oct; 45(10):1538-1548. PubMed ID: 35726085
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Digital Tools-Regulatory Considerations for Application in Clinical Trials.
    Gelis L; Stoeckert I; Podhaisky HP
    Ther Innov Regul Sci; 2023 Jul; 57(4):769-782. PubMed ID: 37195515
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The current status of breakthrough devices designation in the United States and innovative medical devices designation in Korea for digital health software.
    Woo JH; Kim EC; Kim SM
    Expert Rev Med Devices; 2022 Mar; 19(3):213-228. PubMed ID: 35255755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Digital Mental Health Challenges and the Horizon Ahead for Solutions.
    Balcombe L; De Leo D
    JMIR Ment Health; 2021 Mar; 8(3):e26811. PubMed ID: 33779570
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Practical application of digital therapeutics in people with mood disorders.
    Orsolini L; Longo G; Volpe U
    Curr Opin Psychiatry; 2024 Jan; 37(1):9-17. PubMed ID: 37972954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Digital Therapeutics for Improving Effectiveness of Pharmaceutical Drugs and Biological Products: Preclinical and Clinical Studies Supporting Development of Drug + Digital Combination Therapies for Chronic Diseases.
    Biskupiak Z; Ha VV; Rohaj A; Bulaj G
    J Clin Med; 2024 Jan; 13(2):. PubMed ID: 38256537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessing the Potential Risks of Digital Therapeutics (DTX): The DTX Risk Assessment Canvas.
    Denecke K; May R; Gabarron E; Lopez-Campos GH
    J Pers Med; 2023 Oct; 13(10):. PubMed ID: 37888134
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of digital therapeutics and the changing future of healthcare.
    Dang A; Arora D; Rane P
    J Family Med Prim Care; 2020 May; 9(5):2207-2213. PubMed ID: 32754475
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Impact of Digital Therapeutics on Current Health Technology Assessment Frameworks.
    Yan K; Balijepalli C; Druyts E
    Front Digit Health; 2021; 3():667016. PubMed ID: 34713140
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prescription digital therapeutics: A new frontier for pharmacists and the future of treatment.
    Shafai G; Aungst TD
    J Am Pharm Assoc (2003); 2023; 63(4):1030-1034. PubMed ID: 37019379
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Governing Data and Artificial Intelligence for Health Care: Developing an International Understanding.
    Morley J; Murphy L; Mishra A; Joshi I; Karpathakis K
    JMIR Form Res; 2022 Jan; 6(1):e31623. PubMed ID: 35099403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Digital Therapeutics Product Repositioning via Multiplex Link Prediction Based on Genomic, Chemical, and Technological Information.
    Jeon E; Sohn SY
    IEEE J Biomed Health Inform; 2023 Jun; 27(6):2660-2669. PubMed ID: 35994550
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.